Kate Fox

Dr Fox completed a DPhil in microbiology at the University of Oxford, investigating novel phase variable LPS biosynthetic genes in Haemophilus influenzae, during which she gained experience in a wide range of techniques, including Southern hybridisation, PCR, DNA isolation, manipulation and sequencing, SDS PAGE, western blotting, large scale preparation of LPS for structural analysis, bactericidal assays, cell adhesion and uptake assays and colony immunoblotting. She then spent five years as a post-doctoral researcher at the University of Queensland, Australia, focusing on the role of DNA methyltransferases in gene regulation in bacterial pathogens. Other projects included the design and development of live, attenuated vaccines for veterinary pathogens. Dr Fox has many first-author publications in high-ranking journals in the area of microbial pathogenesis. She is now a full-time editor, with extensive editing experience in a broad range of biological disciplines, including molecular biology, microbiology, biotechnology, genomics, epidemiology, biochemistry and medicine. Dr Fox joined Edanz Group as an editor in 2009.